Cargando…
Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341787/ https://www.ncbi.nlm.nih.gov/pubmed/30675301 http://dx.doi.org/10.3892/ol.2018.9812 |
_version_ | 1783389016103583744 |
---|---|
author | Lu, Xin Wu, Zhen Zhao, Xue-Ying Li, Chun-Feng Kan, Shi-Feng |
author_facet | Lu, Xin Wu, Zhen Zhao, Xue-Ying Li, Chun-Feng Kan, Shi-Feng |
author_sort | Lu, Xin |
collection | PubMed |
description | Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially expressed genes (DEGs). Additionally, we re-weighted the PPI network of normal and CLL conditions by means of Pearsons correlation coefficient (PCC). Furthermore, clique-merging method was applied to extract the modules and then the altered modules were screened out. The intersection genes were selected from miss and add genes in the altered modules. The common genes were screened from the intersection genes and DEGs in CLL. A total of 734 DEGs were screened by statistical analysis. In this investigation, there were 1,805 and 703 modules in normal as well as disease PPI network. In addition, 875 altered modules were obtained which included 145 miss genes, 353 add genes and 85 intersection genes. Finally, in-depth analysis revealed 9 mutual genes between the intersection genes and DEGs in CLL. Our analysis revealed several key genes associated with CLL by systematically tracking the dysregulated modules, which might be candidate targets for diagnosis and management of CLL. |
format | Online Article Text |
id | pubmed-6341787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-63417872019-01-23 Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia Lu, Xin Wu, Zhen Zhao, Xue-Ying Li, Chun-Feng Kan, Shi-Feng Oncol Lett Articles Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially expressed genes (DEGs). Additionally, we re-weighted the PPI network of normal and CLL conditions by means of Pearsons correlation coefficient (PCC). Furthermore, clique-merging method was applied to extract the modules and then the altered modules were screened out. The intersection genes were selected from miss and add genes in the altered modules. The common genes were screened from the intersection genes and DEGs in CLL. A total of 734 DEGs were screened by statistical analysis. In this investigation, there were 1,805 and 703 modules in normal as well as disease PPI network. In addition, 875 altered modules were obtained which included 145 miss genes, 353 add genes and 85 intersection genes. Finally, in-depth analysis revealed 9 mutual genes between the intersection genes and DEGs in CLL. Our analysis revealed several key genes associated with CLL by systematically tracking the dysregulated modules, which might be candidate targets for diagnosis and management of CLL. D.A. Spandidos 2019-02 2018-12-07 /pmc/articles/PMC6341787/ /pubmed/30675301 http://dx.doi.org/10.3892/ol.2018.9812 Text en Copyright: © Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Lu, Xin Wu, Zhen Zhao, Xue-Ying Li, Chun-Feng Kan, Shi-Feng Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title | Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title_full | Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title_fullStr | Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title_full_unstemmed | Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title_short | Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
title_sort | systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341787/ https://www.ncbi.nlm.nih.gov/pubmed/30675301 http://dx.doi.org/10.3892/ol.2018.9812 |
work_keys_str_mv | AT luxin systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia AT wuzhen systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia AT zhaoxueying systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia AT lichunfeng systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia AT kanshifeng systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia |